Published in Genes Dev on January 01, 1993
Cloning, functional characterization, and mechanism of action of the B-cell-specific transcriptional coactivator OCA-B. Mol Cell Biol (1995) 2.74
Viral mimicry: common mode of association with HCF by VP16 and the cellular protein LZIP. Genes Dev (1997) 2.27
Role of negative regulation in promoter specificity of the homologous transcriptional activators Ace2p and Swi5p. Mol Cell Biol (1996) 2.20
VP16 targets an amino-terminal domain of HCF involved in cell cycle progression. Mol Cell Biol (1997) 2.07
Heterodimerization of Msx and Dlx homeoproteins results in functional antagonism. Mol Cell Biol (1997) 2.04
Trimethylation of histone H3 lysine 4 by Set1 in the lytic infection of human herpes simplex virus 1. J Virol (2006) 1.65
Three classes of mutations in the A subunit of the CCAAT-binding factor CBF delineate functional domains involved in the three-step assembly of the CBF-DNA complex. Mol Cell Biol (1996) 1.49
Modulation of promoter occupancy by cooperative DNA binding and activation-domain function is a major determinant of transcriptional regulation by activators in vivo. Proc Natl Acad Sci U S A (1996) 1.48
Transcriptional activation by herpes simplex virus type 1 VP16 in vitro and its inhibition by oligopeptides. Mol Cell Biol (1994) 1.31
Interdigitated residues within a small region of VP16 interact with Oct-1, HCF, and DNA. Mol Cell Biol (1997) 1.26
Mechanisms for flexibility in DNA sequence recognition and VP16-induced complex formation by the Oct-1 POU domain. Mol Cell Biol (1995) 1.25
The carboxy-terminal transactivation domain of Oct-4 acquires cell specificity through the POU domain. Mol Cell Biol (1997) 1.25
Differential control of transcription by homologous homeodomain coregulators. Mol Cell Biol (1996) 1.21
Oct-6: a regulator of keratinocyte gene expression in stratified squamous epithelia. Mol Cell Biol (1994) 1.17
OCA-B is a functional analog of VP16 but targets a separate surface of the Oct-1 POU domain. Mol Cell Biol (1997) 1.15
Deformed protein binding sites and cofactor binding sites are required for the function of a small segment-specific regulatory element in Drosophila embryos. EMBO J (1994) 1.14
The HNF1/HNF4-dependent We2 element of woodchuck hepatitis virus controls viral replication and can activate the N-myc2 promoter. J Virol (1996) 1.10
Homeoproteins CDP and SATB1 interact: potential for tissue-specific regulation. Mol Cell Biol (1999) 1.10
Recruitment of octamer transcription factors to DNA by glucocorticoid receptor. Mol Cell Biol (1998) 1.06
Transient reversal of episome silencing precedes VP16-dependent transcription during reactivation of latent HSV-1 in neurons. PLoS Pathog (2012) 1.04
Transcriptional activation domains of the Candida albicans Gcn4p and Gal4p homologs. Eukaryot Cell (2006) 1.03
DNA recognition by the herpes simplex virus transactivator VP16: a novel DNA-binding structure. Mol Cell Biol (2001) 1.00
Transcription factors interacting with herpes simplex virus alpha gene promoters in sensory neurons. Nucleic Acids Res (1995) 0.99
A cultured affair: HSV latency and reactivation in neurons. Trends Microbiol (2012) 0.98
Differential in vivo activation of the class II and class III snRNA genes by the POU-specific domain of Oct-1. Nucleic Acids Res (1997) 0.98
Coactivation by OCA-B: definition of critical regions and synergism with general cofactors. Mol Cell Biol (1998) 0.97
Cellular factors controlling the activity of woodchuck hepatitis virus enhancer II. J Virol (1996) 0.96
Sequence-specific targeting of nuclear signal transduction pathways by homeodomain proteins. Mol Cell Biol (1995) 0.96
The VP16 paradox: herpes simplex virus VP16 contains a long-range activation domain but within the natural multiprotein complex activates only from promoter-proximal positions. J Virol (1997) 0.94
Selected elements of herpes simplex virus accessory factor HCF are highly conserved in Caenorhabditis elegans. Mol Cell Biol (1999) 0.94
Transformation by homeobox genes can be mediated by selective transcriptional repression. EMBO J (1994) 0.93
Neurons differentially control expression of a herpes simplex virus type 1 immediate-early promoter in transgenic mice. J Virol (1995) 0.93
Conserved RY-repeats mediate transactivation of seed-specific promoters by the developmental regulator PvALF. Nucleic Acids Res (1997) 0.91
Specific transcriptional activation in vitro by the herpes simplex virus protein VP16. Nucleic Acids Res (1993) 0.88
Stabilization but not the transcriptional activity of herpes simplex virus VP16-induced complexes is evolutionarily conserved among HCF family members. J Virol (2001) 0.87
Protein and DNA contact surfaces that mediate the selective action of the Phox1 homeodomain at the c-fos serum response element. Mol Cell Biol (1997) 0.87
Oct-2 forms a complex with Oct-1 on the iNOS promoter and represses transcription by interfering with recruitment of RNA PolII by Oct-1. Nucleic Acids Res (2015) 0.82
Role of defective Oct-2 and OCA-B expression in immunoglobulin production and Kaposi's sarcoma-associated herpesvirus lytic reactivation in primary effusion lymphoma. J Virol (2009) 0.78
Transcriptional regulation of the HMGA1 gene by octamer-binding proteins Oct-1 and Oct-2. PLoS One (2013) 0.76
Functional analysis of ground squirrel hepatitis virus enhancer II. J Virol (1998) 0.75
Modeling HSV-1 Latency in Human Embryonic Stem Cell-Derived Neurons. Pathogens (2017) 0.75
Herpes Simplex Virus Establishment, Maintenance, and Reactivation: In Vitro Modeling of Latency. Pathogens (2017) 0.75
The complete nucleotide sequence of the tobacco chloroplast genome: its gene organization and expression. EMBO J (1986) 19.59
Complete genome sequence of enterohemorrhagic Escherichia coli O157:H7 and genomic comparison with a laboratory strain K-12. DNA Res (2001) 15.22
The ubiquitous octamer-binding protein Oct-1 contains a POU domain with a homeo box subdomain. Genes Dev (1988) 8.11
Differential transcriptional activation by Oct-1 and Oct-2: interdependent activation domains induce Oct-2 phosphorylation. Cell (1990) 8.11
Rapid chemical probing of conformation in 16 S ribosomal RNA and 30 S ribosomal subunits using primer extension. J Mol Biol (1986) 7.87
Positional cloning of the mouse circadian clock gene. Cell (1997) 7.79
Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell (1994) 7.23
Secondary structure model for 23S ribosomal RNA. Nucleic Acids Res (1981) 7.12
Prospective evaluation of cancer clinical trial accrual patterns: identifying potential barriers to enrollment. J Clin Oncol (2001) 6.83
Structural analysis of RNA using chemical and enzymatic probing monitored by primer extension. Methods Enzymol (1988) 6.38
Ethidium bromide provides a simple tool for identifying genuine DNA-independent protein associations. Proc Natl Acad Sci U S A (1992) 6.23
Calcium induced release of calcium from the sarcoplasmic reticulum of skinned skeletal muscle fibres. Nature (1970) 5.65
The Oct-1 homoeodomain directs formation of a multiprotein-DNA complex with the HSV transactivator VP16. Nature (1989) 5.43
Kirsten ras mutations in patients with colorectal cancer: the 'RASCAL II' study. Br J Cancer (2001) 5.36
Mechanism of ribosomal subunit association: discrimination of specific sites in 16 S RNA essential for association activity. J Mol Biol (1979) 4.88
Nucleotide sequence of AKV murine leukemia virus. J Virol (1984) 4.58
Antimicrobial activity of DU-6859, a new potent fluoroquinolone, against clinical isolates. Antimicrob Agents Chemother (1992) 4.43
Discrete elements within the SV40 enhancer region display different cell-specific enhancer activities. EMBO J (1987) 4.28
The SV40 enhancer is composed of multiple functional elements that can compensate for one another. Cell (1986) 4.25
A randomized trial comparing the effect of rofecoxib, a cyclooxygenase 2-specific inhibitor, with that of ibuprofen on the gastroduodenal mucosa of patients with osteoarthritis. Rofecoxib Osteoarthritis Endoscopy Study Group. Gastroenterology (1999) 4.13
The SV40 enhancer contains two distinct levels of organization. Nature (1988) 3.98
Crystal structure of the Oct-1 POU domain bound to an octamer site: DNA recognition with tethered DNA-binding modules. Cell (1994) 3.98
The VP16 accessory protein HCF is a family of polypeptides processed from a large precursor protein. Cell (1993) 3.80
Coding of modified body schema during tool use by macaque postcentral neurones. Neuroreport (1996) 3.78
Proposal for a new clinical entity, IgG4-positive multiorgan lymphoproliferative syndrome: analysis of 64 cases of IgG4-related disorders. Ann Rheum Dis (2008) 3.77
Mitochondrial DNA mutations as an important contributor to ageing and degenerative diseases. Lancet (1989) 3.69
A 100-kD HeLa cell octamer binding protein (OBP100) interacts differently with two separate octamer-related sequences within the SV40 enhancer. Genes Dev (1987) 3.45
Mixed allogeneic chimerism and renal allograft tolerance in cynomolgus monkeys. Transplantation (1995) 3.18
Promoter-selective activation domains in Oct-1 and Oct-2 direct differential activation of an snRNA and mRNA promoter. Cell (1992) 2.97
Interactions of a small RNA with antibiotic and RNA ligands of the 30S subunit. Nature (1994) 2.96
The POU domain is a bipartite DNA-binding structure. Nature (1988) 2.92
Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease. Proc Natl Acad Sci U S A (1996) 2.88
FOG-2, a cofactor for GATA transcription factors, is essential for heart morphogenesis and development of coronary vessels from epicardium. Cell (2000) 2.86
A single-point mutation in HCF causes temperature-sensitive cell-cycle arrest and disrupts VP16 function. Genes Dev (1997) 2.84
Efficient gene activation in mammalian cells by using recombinant adenovirus expressing site-specific Cre recombinase. Nucleic Acids Res (1995) 2.79
Duplications of a mutated simian virus 40 enhancer restore its activity. Nature (1985) 2.75
Human Fas ligand: gene structure, chromosomal location and species specificity. Int Immunol (1994) 2.74
Serum matrix metalloproteinase 3 as a predictor of the degree of joint destruction during the six months after measurement, in patients with early rheumatoid arthritis. Arthritis Rheum (2000) 2.72
Risk of poliomyelitis importation and re-emergence in Laos. Lancet (2000) 2.64
Induction of erythroid differentiation in murine virus infected eythroleukemia cells by highly polar compounds. Proc Natl Acad Sci U S A (1975) 2.60
Rapid identification of dengue virus serotypes by using polymerase chain reaction. J Clin Microbiol (1991) 2.60
Mitochondrial genotype associated with longevity. Lancet (1998) 2.58
Early detection of silent ischaemic heart disease by 24-hour electrocardiographic monitoring of active subjects. Br Heart J (1974) 2.55
Loss of HCF-1-chromatin association precedes temperature-induced growth arrest of tsBN67 cells. Mol Cell Biol (2001) 2.47
Oxidative stress activates extracellular signal-regulated kinases through Src and Ras in cultured cardiac myocytes of neonatal rats. J Clin Invest (1997) 2.44
Activation of protein kinase C by tyrosine phosphorylation in response to H2O2. Proc Natl Acad Sci U S A (1997) 2.42
Activation of the U2 snRNA promoter by the octamer motif defines a new class of RNA polymerase II enhancer elements. Genes Dev (1988) 2.38
OBP100 binds remarkably degenerate octamer motifs through specific interactions with flanking sequences. Genes Dev (1988) 2.34
A TBP complex essential for transcription from TATA-less but not TATA-containing RNA polymerase III promoters is part of the TFIIIB fraction. Cell (1992) 2.32
Defective mammopoiesis, but normal hematopoiesis, in mice with a targeted disruption of the prolactin gene. EMBO J (1997) 2.28
Viral mimicry: common mode of association with HCF by VP16 and the cellular protein LZIP. Genes Dev (1997) 2.27
A single amino acid exchange transfers VP16-induced positive control from the Oct-1 to the Oct-2 homeo domain. Genes Dev (1992) 2.23
Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease. Biochem Biophys Res Commun (1989) 2.23
Diethyl pyrocarbonate: a chemical probe for secondary structure in negatively supercoiled DNA. Proc Natl Acad Sci U S A (1985) 2.22
The HCF repeat is an unusual proteolytic cleavage signal. Genes Dev (1995) 2.22
The herpes simplex virus trans-activator VP16 recognizes the Oct-1 homeo domain: evidence for a homeo domain recognition subdomain. Genes Dev (1991) 2.22
Six chloroplast genes (ndhA-F) homologous to human mitochondrial genes encoding components of the respiratory chain NADH dehydrogenase are actively expressed: determination of the splice sites in ndhA and ndhB pre-mRNAs. Mol Gen Genet (1987) 2.14
Function of Light in the Light-induced Geotropic Response in Zea Roots. Plant Physiol (1981) 2.13
Nucleotide sequence of the 3' terminus of E. coli 16S ribosomal RNA. Mol Biol Rep (1974) 2.13
Erythromycin reduces neutrophils and neutrophil-derived elastolytic-like activity in the lower respiratory tract of bronchiolitis patients. Am Rev Respir Dis (1992) 2.12
Convulsions after ropivacaine 300 mg for brachial plexus block. Br J Anaesth (2008) 2.09
Efficacy of lymphatic mapping, sentinel lymphadenectomy, and selective complete lymph node dissection as a therapeutic procedure for early-stage melanoma. Ann Surg Oncol (1999) 2.08
Expression of human telomerase subunits and correlation with telomerase activity in cervical cancer. Cancer Res (1998) 2.08
Concordance between telepathologic diagnosis and conventional histopathologic diagnosis: a multiobserver store-and-forward study on 20 skin specimens. Arch Dermatol (2002) 2.07
VP16 targets an amino-terminal domain of HCF involved in cell cycle progression. Mol Cell Biol (1997) 2.07
A fragment of 23S RNA containing a nucleotide sequence complementary to a region of 5S RNA. FEBS Lett (1975) 2.07
International transmission of uncompressed endoscopic surgery images via superfast broadband Internet connections. Surg Endosc (2005) 2.05
Expression of cyclooxygenase-2 in human hepatocellular carcinoma: relevance to tumor dedifferentiation. Hepatology (1999) 2.05
New neuropeptides containing carboxy-terminal RFamide and their receptor in mammals. Nat Cell Biol (2000) 2.05
Therapeutic hypercapnia reduces pulmonary and systemic injury following in vivo lung reperfusion. Am J Respir Crit Care Med (2000) 2.05
Molecular bases of odor discrimination: Reconstitution of olfactory receptors that recognize overlapping sets of odorants. J Neurosci (2001) 2.04
Sex differences in management and outcome after acute myocardial infarction in the 1990s: A prospective observational community-based study. Israeli Thrombolytic Survey Group. Circulation (2000) 2.02
Poly(L-proline)-binding proteins from chick embryos are a profilin and a profilactin. Eur J Biochem (1985) 2.01
A new role for hypoxia in tumor progression: induction of fragile site triggering genomic rearrangements and formation of complex DMs and HSRs. Mol Cell (1998) 2.00
The internal biliary fistula--reappraisal of incidence, type, diagnosis and management of 33 consecutive cases. HPB Surg (1997) 2.00
Somatically acquired recombinant murine leukemia proviruses in thymic leukemias of AKR/J mice. J Virol (1983) 1.99
Symptomatic myopathy associated with interferon therapy for chronic hepatitis C. Lancet (1995) 1.99
Internet-based program for automatic discrimination of dermoscopic images between melanomas and Clark naevi. Br J Dermatol (2004) 1.99
Erythroid cell differentiation: murine erythroleukemia cell variant with unique pattern of induction by polar compounds. Proc Natl Acad Sci U S A (1976) 1.99
Polyglutamine length-dependent interaction of Hsp40 and Hsp70 family chaperones with truncated N-terminal huntingtin: their role in suppression of aggregation and cellular toxicity. Hum Mol Genet (2000) 1.99
Mitochondrial mutation in fatal infantile cardiomyopathy. Lancet (1990) 1.98
Increased expression of transforming growth factor-beta1 in small airway epithelium from tobacco smokers and patients with chronic obstructive pulmonary disease (COPD). Am J Respir Crit Care Med (2001) 1.98
Neuropilin-1 extracellular domains mediate semaphorin D/III-induced growth cone collapse. Neuron (1998) 1.96
Afadin: A key molecule essential for structural organization of cell-cell junctions of polarized epithelia during embryogenesis. J Cell Biol (1999) 1.96
Impact of cerebral microcirculatory changes on cerebral blood flow during cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Stroke (2000) 1.94
Evaluation of immunoreactivity for erbB-2 protein as a marker of poor short term prognosis in gastric cancer. Cancer Res (1991) 1.92
Progressive impairment of kidneys and reproductive organs in mice lacking Rho GDIalpha. Oncogene (1999) 1.91
Molecular cloning and characterization of a new member of the RAC protein kinase family: association of the pleckstrin homology domain of three types of RAC protein kinase with protein kinase C subspecies and beta gamma subunits of G proteins. Biochem Biophys Res Commun (1995) 1.90
Small molecules that selectively block RNA binding of HIV-1 Rev protein inhibit Rev function and viral production. Cell (1993) 1.90
Physical and functional mapping of Tn2603, a transposon encoding ampicillin, streptomycin, sulfonamide, and mercury resistance. Mol Gen Genet (1981) 1.88
Resistance of Fc receptor- deficient mice to fatal glomerulonephritis. J Clin Invest (1998) 1.88
IL-18 induction of IgE: dependence on CD4+ T cells, IL-4 and STAT6. Nat Immunol (2000) 1.86
A randomised phase III trial comparing gemcitabine with surgery-only in patients with resected pancreatic cancer: Japanese Study Group of Adjuvant Therapy for Pancreatic Cancer. Br J Cancer (2009) 1.84
Treatment of torsade de pointes with magnesium sulfate. Circulation (1988) 1.84
Localization of the binding site for protein S4 on 16 S ribosomal RNA by chemical and enzymatic probing and primer extension. J Mol Biol (1986) 1.83
Genes for the eight ribosomal proteins are clustered on the chloroplast genome of tobacco (Nicotiana tabacum): similarity to the S10 and spc operons of Escherichia coli. Proc Natl Acad Sci U S A (1986) 1.83
Protection of specific sites in 23 S and 5 S RNA from chemical modification by association of 30 S and 50 S ribosomes. J Mol Biol (1979) 1.82
Transposition of the oxacillin-hydrolyzing penicillinase gene. J Bacteriol (1981) 1.82